VL285
VL285 is a potent VHL ligand with an IC50 of 0.34 μM[1].
Product Specifications
CAS Number
[1448188-57-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Ligands for E3 Ligase
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/VL285.html
Purity
99.34
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(N=CS1)=C1C2=CC=C(CNC([C@@H]3C[C@@H](O)CN3C([C@@H](N4CC(C=CC=C5)=C5C4=O)C(C)C)=O)=O)C=C2
Molecular Formula
C29H32N4O4S
Molecular Weight
532.65
Precautions
H302, H315, H319, H335
References & Citations
[1]Buckley DL, et al. HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins. ACS Chem Biol. 2015 Aug 21;10 (8) :1831-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Von Hippel-Lindau (VHL)
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15188250 1 Vial
Lentiviral mouse Asb3 shRNA (UAS) - Lentiviral mouse Asb3 shRNA (UAS) (100)
Ask
View Details MBS1016738-01 0.02 mg (E-Coli)
Recombinant Coxiella burnetii Crossover junction endodeoxyribonuclease RuvC (ruvC)
Ask
View Details